• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫内药物暴露的生化筛查

Biochemical Screening for in utero Drug Exposure.

作者信息

Wright Tricia E

机构信息

Department of Obstetrics, Gynecology and Women's Health University of Hawaii John A. Burns School of Medicine, 1319 Punahou St., Ste 824, Honolulu, HI 96826, USA.

出版信息

Drug Metab Lett. 2015;9(2):65-71. doi: 10.2174/1872312809666150904182334.

DOI:10.2174/1872312809666150904182334
PMID:26411469
Abstract

Licit and illicit drug use is a common complication of pregnancy. Accurate information on drug use is difficult to obtain for many reasons as women fear self-disclosure or consenting for drug testing due to stigma, guilt, and fear of social and legal harm. As information about drug use is clinically very important, biochemical testing is an important adjunct to careful maternal history. In addition, research studies depend on accurate measures of exposure when reporting risks of a substance. This paper delineates available matrices for and methods of biochemical drug testing in pregnant women and neonates.

摘要

合法及非法药物使用是孕期常见的并发症。由于女性担心因污名、内疚以及对社会和法律伤害的恐惧而自我披露或同意进行药物检测,所以出于多种原因很难获得关于药物使用的准确信息。由于药物使用信息在临床上非常重要,生化检测是仔细询问母亲病史的重要辅助手段。此外,研究报告某种物质的风险时,依赖于对暴露情况的准确测量。本文阐述了孕妇和新生儿生化药物检测可用的样本基质及方法。

相似文献

1
Biochemical Screening for in utero Drug Exposure.宫内药物暴露的生化筛查
Drug Metab Lett. 2015;9(2):65-71. doi: 10.2174/1872312809666150904182334.
2
Drug abuse's smallest victims: in utero drug exposure.药物滥用最小的受害者:子宫内药物暴露。
Forensic Sci Int. 2002 Aug 14;128(1-2):20-30. doi: 10.1016/s0379-0738(02)00160-3.
3
Biological matrices for the evaluation of in utero exposure to drugs of abuse.用于评估子宫内药物滥用暴露情况的生物基质。
Ther Drug Monit. 2007 Dec;29(6):711-34. doi: 10.1097/FTD.0b013e31815c14ce.
4
Opioid detection in maternal and neonatal hair and meconium: characterization of an at-risk population and implications to fetal toxicology.在产妇和新生儿的头发和胎粪中检测阿片类药物:高危人群的特征及对胎儿毒理学的影响。
Ther Drug Monit. 2010 Jun;32(3):318-23. doi: 10.1097/FTD.0b013e3181dca48b.
5
Drugs of abuse testing in meconium.胎粪中的药物滥用检测
Clin Chim Acta. 2006 Apr;366(1-2):101-11. doi: 10.1016/j.cca.2005.10.028. Epub 2006 Jan 17.
6
Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.母婴二元组中检测子宫内阿片类药物和可卡因暴露的生物学筛查与诊断指标比较
Ther Drug Monit. 2017 Dec;39(6):640-647. doi: 10.1097/FTD.0000000000000447.
7
Detection of Drug-Exposed Newborns.药物暴露新生儿的检测
Ther Drug Monit. 2018 Apr;40(2):166-185. doi: 10.1097/FTD.0000000000000485.
8
Maternal hair testing for the assessment of fetal exposure to drug of abuse during early pregnancy: Comparison with testing in placental and fetal remains.母体头发检测评估早孕期间胎儿暴露于药物滥用的情况:与胎盘和胎儿组织检测的比较。
Forensic Sci Int. 2012 May 10;218(1-3):92-6. doi: 10.1016/j.forsciint.2011.10.022. Epub 2011 Oct 27.
9
Accumulation of cocaine in maternal and fetal hair; the dose response curve.
Life Sci. 1992;50(18):1333-41. doi: 10.1016/0024-3205(92)90284-v.
10
Testing ethylglucuronide in maternal hair and nails for the assessment of fetal exposure to alcohol: comparison with meconium testing.检测母体头发和指甲中的乙基葡萄糖醛酸苷以评估胎儿暴露于酒精的情况:与检测胎粪的比较。
Ther Drug Monit. 2013 Jun;35(3):402-7. doi: 10.1097/FTD.0b013e318283f719.

引用本文的文献

1
Emerging and Legacy Perfluoroalkyl Substances in Breastfed Chinese Infants: Renal Clearance, Body Burden, and Implications.母乳喂养的中国婴儿体内新兴和传统全氟烷基物质:肾清除率、身体负担和影响。
Environ Health Perspect. 2023 Mar;131(3):37003. doi: 10.1289/EHP11403. Epub 2023 Mar 2.
2
Screening Pregnant Women and Their Neonates for Illicit Drug Use: Consideration of the Integrated Technical, Medical, Ethical, Legal, and Social Issues.对孕妇及其新生儿进行非法药物使用筛查:综合技术、医学、伦理、法律和社会问题的考量
Front Pharmacol. 2018 Aug 28;9:961. doi: 10.3389/fphar.2018.00961. eCollection 2018.